Bank of New York Mellon’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-187,963
Closed -$7.08M 4542
2021
Q1
$7.08M Buy
187,963
+13,967
+8% +$526K ﹤0.01% 2274
2020
Q4
$2.96M Buy
173,996
+52,443
+43% +$892K ﹤0.01% 2619
2020
Q3
$572K Sell
121,553
-1,973
-2% -$9.28K ﹤0.01% 3423
2020
Q2
$753K Sell
123,526
-16,616
-12% -$101K ﹤0.01% 3261
2020
Q1
$318K Buy
140,142
+10,788
+8% +$24.5K ﹤0.01% 3574
2019
Q4
$594K Sell
129,354
-28,591
-18% -$131K ﹤0.01% 3503
2019
Q3
$612K Sell
157,945
-2,450
-2% -$9.49K ﹤0.01% 3423
2019
Q2
$967K Sell
160,395
-10,577
-6% -$63.8K ﹤0.01% 3232
2019
Q1
$2.29M Sell
170,972
-219
-0.1% -$2.94K ﹤0.01% 2709
2018
Q4
$1.59M Sell
171,191
-1,040
-0.6% -$9.68K ﹤0.01% 2843
2018
Q3
$2.4M Buy
172,231
+12,076
+8% +$168K ﹤0.01% 2743
2018
Q2
$2.53M Sell
160,155
-8,586
-5% -$136K ﹤0.01% 2726
2018
Q1
$2.9M Buy
168,741
+18,496
+12% +$318K ﹤0.01% 2620
2017
Q4
$3.29M Sell
150,245
-75,178
-33% -$1.65M ﹤0.01% 2558
2017
Q3
$9.22M Sell
225,423
-2,927
-1% -$120K ﹤0.01% 2030
2017
Q2
$6.88M Buy
228,350
+4,474
+2% +$135K ﹤0.01% 2162
2017
Q1
$8.09M Sell
223,876
-629
-0.3% -$22.7K ﹤0.01% 2077
2016
Q4
$11.3M Buy
224,505
+80,047
+55% +$4.01M ﹤0.01% 1899
2016
Q3
$7.58M Sell
144,458
-4,603
-3% -$242K ﹤0.01% 2011
2016
Q2
$6.16M Buy
149,061
+17,694
+13% +$732K ﹤0.01% 2103
2016
Q1
$5.34M Buy
131,367
+9,435
+8% +$383K ﹤0.01% 2153
2015
Q4
$5.06M Buy
121,932
+10,113
+9% +$420K ﹤0.01% 2208
2015
Q3
$1.72M Sell
111,819
-13,149
-11% -$202K ﹤0.01% 2818
2015
Q2
$3.1M Buy
124,968
+37,921
+44% +$942K ﹤0.01% 2641
2015
Q1
$1.99M Buy
87,047
+23,051
+36% +$527K ﹤0.01% 2867
2014
Q4
$1.73M Sell
63,996
-3,903
-6% -$105K ﹤0.01% 2965
2014
Q3
$796K Sell
67,899
-1,741
-3% -$20.4K ﹤0.01% 3421
2014
Q2
$1.08M Buy
69,640
+50,426
+262% +$784K ﹤0.01% 3269
2014
Q1
$378K Buy
19,214
+7,825
+69% +$154K ﹤0.01% 3654
2013
Q4
$191K Buy
+11,389
New +$191K ﹤0.01% 3831